MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1212/wnl.0000000000007323

Медицинская библиотека · Neurology · 2019

KLOTHO heterozygosity attenuates APOE4-related amyloid burden in preclinical AD.

Erickson Claire M, Schultz Stephanie A, Oh Jennifer M, Darst Burcu F, Ma Yue, Norton Derek, Betthauser Tobey, Gallagher Catherine L, Carlsson Cynthia M, Bendlin Barbara B, Asthana Sanjay, Hermann Bruce P, Sager Mark A, Blennow Kaj, Zetterberg Henrik, Engelman Corinne D, Christian Bradley T, Johnson Sterling C, Dubal Dena B, Okonkwo Ozioma C

СтатьяПеревод пока не подготовлен

Аннотация

OBJECTIVE

To examine whether the KLOTHO gene variant KL-VS attenuates APOE4-associated β-amyloid (Aβ) accumulation in a late-middle-aged cohort enriched with Alzheimer disease (AD) risk factors.

METHODS

Three hundred nine late-middle-aged adults from the Wisconsin Registry for Alzheimer's Prevention and the Wisconsin Alzheimer's Disease Research Center were genotyped to determine KL-VS and APOE4 status and underwent CSF sampling (n = 238) and/or 11C-Pittsburgh compound B (PiB)-PET imaging (n = 183). Covariate-adjusted regression analyses were used to investigate whether APOE4 exerted expected effects on Aβ burden. Follow-up regression analyses stratified by KL-VS genotype (i.e., noncarrier vs heterozygous; there were no homozygous individuals) evaluated whether the influence of APOE4 on Aβ was different among KL-VS heterozygotes compared to noncarriers.

RESULTS

APOE4 carriers exhibited greater Aβ burden than APOE4-negative participants. This effect was stronger in CSF (t = -5.12, p < 0.001) compared with PiB-PET (t = 3.93, p < 0.001). In the stratified analyses, this APOE4 effect on Aβ load was recapitulated among KL-VS noncarriers (CSF: t = -5.09, p < 0.001; PiB-PET: t = 3.77, p < 0 .001). In contrast, among KL-VS heterozygotes, APOE4-positive individuals did not exhibit higher Aβ burden than APOE4-negative individuals (CSF: t = -1.03, p = 0.308; PiB-PET: t = 0.92, p = 0.363). These differential APOE4 effects remained after KL-VS heterozygotes and noncarriers were matched on age and sex.

CONCLUSION

In a cohort of at-risk late-middle-aged adults, KL-VS heterozygosity was associated with an abatement of APOE4-associated Aβ aggregation, suggesting KL-VS heterozygosity confers protections against APOE4-linked pathways to disease onset in AD.

Для цитирования: Erickson Claire M, Schultz Stephanie A, Oh Jennifer M, Darst Burcu F, Ma Yue, Norton Derek, Betthauser Tobey, Gallagher Catherine L, Carlsson Cynthia M, Bendlin Barbara B, Asthana Sanjay, Hermann Bruce P, Sager Mark A, Blennow Kaj, Zetterberg Henrik, Engelman Corinne D, Christian Bradley T, Johnson Sterling C, Dubal Dena B, Okonkwo Ozioma C. KLOTHO heterozygosity attenuates APOE4-related amyloid burden in preclinical AD.. Neurology. 2019. DOI: 10.1212/wnl.0000000000007323.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.